Skip to main content

Table 2 The antimicrobial sensitivity tests of MSSA and MRSA isolates by disk diffusion method

From: Ability of biofilm production and molecular analysis of spa and ica genes among clinical isolates of methicillin-resistant Staphylococcus aureus

AntibioticMSSA (n = 122)MRSA (n = 24)
Susceptible N (%)Intermediate N (%)Resistant N (%)Susceptible N (%)Intermediate N (%)Resistant N (%)
Erythromycin62 (50.8)32 (26.2)28 (23.0)5 (20.8)2 (8.4)17 (70.8)
Clindamycin100 (82.0)14 (11.5)8 (6.5)6 (25.0)4 (16.7)14 (58.3)
Cefoxitin122 (83.6)0 (0.0)0 (0.0)0 (0.0)0 (0.0)24 (16.4)
Cefazolin119 (97.5)2 (1.7)1 (0.8)11 (45.8)0 (0.0)13 (54.2)
Linezolid120 (98.4)0 (0.0)2 (1.6)23 (95.8)0 (0.0)1 (4.2)
Trimethoprim/sulfamethoxazole112 (91.8)4 (3.3)6 (4.9)16 (66.7)0 (0.0)8 (33.3)